In a randomised trial of 540 participants with major depressive disorder (493 analysed), a decision-support tool to personalise antidepressant choice reduced 8-week discontinuation vs usual care (17% vs 27%; aRR 0.62); open-label, with much missing data.
RCTn = 540
Cipriani et al. A Decision-Support System to Personalize Antidepressant Treatment in Major Depressive Disorder: A Randomized Clinical Trial